Table 2: Compare the mean of NCV in treated patients with phenobarbital by type of nerves.
Type of nerves |
Drugs |
Mean |
P - value |
Median
|
Phenobarbital in baseline |
56 |
0.038
|
Control |
58.7 |
||
Median
|
phenobarbital in baseline |
56 |
0.065
|
phenobarbital six month late |
55.4 |
||
Ulnar
|
phenobarbital in baseline |
54.2 |
0.06
|
Control |
50.8 |
||
Ulnar
|
phenobarbital in baseline |
54.2 |
0.057
|
Phenobarbital six month late |
53.2 |
||
Sural
|
phenobarbital in Baseline |
45.2 |
0.001
|
Control |
50.6 |
||
Sural
|
phenobarbital in baseline |
45.2 |
0.06
|
Phenobarbital six month late |
43.8 |
||
Peroneal
|
phenobarbital in baseline |
42.8 |
0.011
|
Control |
46.4 |
||
Peroneal |
phenobarbital in baseline |
42.8 |
0.053 |
Phenobarbital six month late |
41.2 |